Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus
8 September 2020
The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19. The study is one of three new UK-wide studies receiving a share of £8.4 million from UK Research...
8 September 2020
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease. PCR and antibody tests both have limitations...
Antiretroviral therapy fails to treat one-third of HIV patients in Malawi hospital
8 September 2020
Antiretroviral therapy (ART) failure and drug resistance are extremely common in patients living with HIV who are admitted to hospital in Malawi, according to new research published in Lancet HIV . These important findings highlight the threat posed by drug resistant HIV and call for rapid tests for drug resistant virus...
© 2020 University of Cambridge
